Vahé A. Sarkissian

Scientific Advisory Board

David C. Bell, PhD, FRMS

Michael F. Holick, MD, PhD

W. Kelley Thomas, PhD


Management Team

William R. Glover III
The founder of ZS Genetics, Mr. Glover combines scientific vision, an engineer’s training, and a solid background in risk-aversion project management, economics and recruiting. Before inventing the technology behind ZS Genetics, he worked as an energy industry economist, an energy industry management consultant, and a small business strategy consultant, running the US Middle Market Strategy Practice for Cap Gemini Ernst & Young. Earlier, he worked for Bechtel Corp., designing radiation safety systems for commercial nuclear power plants. Mr. Glover holds a BS in chemical engineering from CSU-Long Beach and an MBA from the Darden School at the University of Virginia.

Thomas D. Abert
ZS Genetic’s first investor, Mr. Abert offers a rich background in technology management, helping engineers move innovative technologies into commercial markets, and experience working with start-ups and finance. Highlights include helping launch and grow Hifi.com, a start-up venture for Cambridge SoundWorks, and helping PC Connection launch and manage their online business and service center. Early technology management experience was at AT&T, including Bell Labs, where he helped develop global multimedia networks and applications. His career began in finance, in both corporate finance and trading. Mr. Abert holds an AS in computer science and a BA in music theory from Keene State College, and an MBA from the Darden School at the University of Virginia.

Scott A. McCallister
Mr. McCallister co-invented the ZSG microarray design and solved the principal research problems for our expression application. Scott is the former President of Diginexus, a developer of e-business and e-commerce solutions. He started McCallister Consulting after leaving Cap Gemini Ernst & Young; he moved to CGE&Y from a partner position at Ernst & Young U.S., where he was National Director of Planning. Earlier, he was Senior Vice President of Marketing and Planning at Infocore, Inc., an entrepreneurial telecommunications services company. Scott’s formative business experience was at Strategic Planning Associates, a strategy consulting firm. Mr. McCallister has a BA in mathematics from Dartmouth College and an MBA from the Wharton School at the University of Pennsylvania.

Richard W. Smith
Mr. Smith manages the various R&D projects, including budgets, technical progress and the West Coast vendor relationships, especially semiconductor chip designers and fabricators. From 1997 through 2004, Rich held various management positions within Intel Corporation, most recently in Intel Capital where he was involved in the incubation of several successful businesses. Prior to Intel, Mr. Smith held positions with Cummins Engine Company and General Electric and served in various Officer roles with the United States Army. He also serves as a Director of Raining Data Corporation (Ticker: RDTA). Mr. Smith holds a BS in Civil Engineering from the United States Military Academy and an MBA from the Darden School at the University of Virginia.

Richard E. Clark
Mr. Clark has 30 years of financial and operating experience primarily serving as Controller or CFO for entrepreneurial and rapidly growing biotech, high tech, and consumer products companies. His background includes both manufacturing and services with design and implementation of scalable processes, systems infrastructure, P&L management tools, and business development models. He has negotiated several purchases and dispositions of divisions, subsidiaries and parent corporations as well as helped raise private debt, equity, and IPO proceeds. Mr. Clark began his career practicing as a CPA for Arthur Andersen & Co. He has a BSBA from Northeastern University and an MBA from the University of Wisconsin.

Board of Directors

Denise Drace-Brownell
Senior Managing Director at Epsilon Securities, LLC, affiliated with the Psilos Group, a successful healthcare private equity firm. With extensive strategic advisory, M&A, licensing, intellectual property, fund raising and transactions experience, she has a track record in solving complex business challenges. She has held CEO, VP Corporate Development and General Counsel positions for a number of drug and medical technology companies. Earlier she was Practice President of the medical branding unit of McCann Worldgroup, and a corporate attorney in Akzo Nobel’s US M&A unit. Her clients have included Fortune 500s, mid-size, and development stage companies, including J&J, Myriad Genetics and Chevron.

Frank E. Ferguson
President of Curriculum Associates, Inc. (www.CAInc.com). Mr. Ferguson is an active investor and member of the board or advisor for several other companies, including: EdTech Networks, Way Systems, Net Clarity, and DigitalBrix. He has been president of several corporations, including Bose Corporation for seven years, and Curriculum Associates, of which he is a founder and it's President.

Jane E. Hager
Founder, CEO, President of Prescott Investment Corp., President of Pinnacle Mountain Partners; Managing Member, Angelfish Investments and Gulf Coast Investment Partners. Ms. Hager has extensive experience in the founding and management of public life sciences companies, including: IGI, Novavax, and National Medical Care. She also has extensive banking industry experience, including: founding director for Centrix Bank and Trust (where she is head of the Audit Committee), and director for Fleet Bank – New Hampshire.

Scientific Advisory Board

David C. Bell, PhD, FRMS
Dr. Bell, is Lecturer in Applied Physics at the School of Engineering and
Applied Sciences at Harvard University. He also manages the imaging and
analysis facility at the Center for Nanoscale Systems which is part of the
Faculty of Arts and Sciences at Harvard. His current research interests
include; nanocomposites and nanowire materials. Investigating new mechanisms
for materials imaging and analysis with charged particle beams, electron
aberration determination, correction and the measurements and the
application with analytical microscopy methods for advanced and adaptive
correlative microscopy. He is widely published in journals and books and
holds several patents. Dr. Bell did his postdoctoral studies at MIT, and
received his Ph.D. from the University of Melbourne, Australia. He is a
member a member of the Microscopy Society of America and Fellow of the Royal
Microscopical Society, U.K.

Michael F. Holick, MD, PhD
Dr. Holick is a renowned endocrinologist and professor of medicine, biophysics and physiology at Boston University School of Medicine. He has extensively researched the sources and effects of Vitamin D on the body. In addition to his many Academic and Hospital appointments, Dr. Holick also has an extensive background with life sciences companies, including: A&D Bioscience, Strakan USA, IGI, Manhattan Pharmaceuticals, and Bridge to Life. He is the inventor of 42 approved or pending patents, holds numerous other awards, and has an extensive number of publications.

More information is available on Dr. Holick at www.UVAdvantage.org.

W. Kelley Thomas, PhD
Dr. Thomas is the Hubbard Professor in Genomics and Director of the Hubbard Center for Genome Studies, University of New Hampshire. Dr. Thomas has a long academic career in genomics at the University of Missouri – Kansas City, and University of California – Berkeley, in addition to the University of New Hampshire. He has over 40 publications.

More information on Dr. Thomas is available at hcgs.unh.edu/staff/